Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adverum Biotechnologies (GB:0HA3)
LSE:0HA3
RESEARCH TOOLSreports
Adverum Biotechnologies (0HA3) Share Price & Analysis
1 Followers
0HA3 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.41 - $29.50
Previous Close$11.52
Volume52.00
Average Volume (3M)2.79K
Market Cap
$239.30M
Enterprise Value$217.81M
Total Cash (Recent Filing)$96.53M
Total Debt (Recent Filing)$75.04M
Price to Earnings (P/E)N/A
Beta0.95
Next Earnings
May 09, 2024EPS Estimate
-$1.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding20,754,915
10 Day Avg. Volume838
30 Day Avg. Volume2,786
Standard Deviation0.24
R-Squared0.01
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.92
Price to Sales (P/S)100.31
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue60.50
Enterprise Value/Gross Profit60.50
Enterprise Value/Ebitda-2.15
Forecast
1Y Price Target
$40.00Price Target Upside247.22% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Adverum Biotechnologies News
0HA3 FAQ
What was Adverum Biotechnologies’s price range in the past 12 months?
Adverum Biotechnologies lowest share price was $7.41 and its highest was $29.50 in the past 12 months.
What is Adverum Biotechnologies’s market cap?
Currently, no data Available
When is Adverum Biotechnologies’s upcoming earnings report date?
Adverum Biotechnologies’s upcoming earnings report date is May 09, 2024 which is in 23 days.
How were Adverum Biotechnologies’s earnings last quarter?
Adverum Biotechnologies released its earnings results on Mar 18, 2024. The company reported -$2.3 earnings per share for the quarter, beating the consensus estimate of -$3.359 by $1.059.
Is Adverum Biotechnologies overvalued?
According to Wall Street analysts Adverum Biotechnologies’s price is currently Undervalued.
Does Adverum Biotechnologies pay dividends?
Adverum Biotechnologies does not currently pay dividends.
What is Adverum Biotechnologies’s EPS estimate?
Adverum Biotechnologies’s EPS estimate is -$1.41.
How many shares outstanding does Adverum Biotechnologies have?
Currently, no data Available
What happened to Adverum Biotechnologies’s price movement after its last earnings report?
Adverum Biotechnologies reported an EPS of -$2.3 in its last earnings report, beating expectations of -$3.359. Following the earnings report the stock price went down -5.58%.
Which hedge fund is a major shareholder of Adverum Biotechnologies?
Among the largest hedge funds holding Adverum Biotechnologies’s share is Versant Venture Management, LLC. It holds Adverum Biotechnologies’s shares valued at 4M.
---
Adverum Biotechnologies Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$40.00 (247.22% Upside)
$40.00 (247.22% Upside)
Insider Transactions
Bought Shares
Worth $310.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
37.26%
12-Months-Change
Fundamentals
Return on Equity
-88.43%
Trailing 12-Months
Asset Growth
-43.90%
Trailing 12-Months
Company Description
Adverum Biotechnologies
Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich's ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr. and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Menlo Park, CA.
---
0HA3 Stock 12 Months Forecast
Average Price Target
$40.00
▲(247.22% Upside)
Technical Analysis
Adverum Biotechnologies
―
Advaxis
―
Adaptimmune Therapeutics
―
Akebia Therapeutics
―
Best Analysts Covering 0HA3
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
-12.83%
reiterated a buy rating 23 days ago
Copying Joon Lee's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -12.83% per trade.
---